Study
Resveratrol and immunomodulation: tabular summary of human trial endpoints
A tabular review of resveratrol's inflammatory and immune endpoints across published human studies.
Summary Does resveratrol improve inflammation or immune health in people? Show / hide ↓
Researchers reviewed published human trials of resveratrol, a compound found in grapes and red wine. They compared changes in inflammation markers, which are blood signs of immune activity, across different studies. Some studies found small drops in CRP, a blood marker linked with inflammation, and TNF-alpha, an immune-system chemical, especially in people with metabolic problems. Results were mixed in healthy adults, and resveratrol did not clearly reduce infections. This was a review, not a new trial, so it added no new participants.
What this means for you: This review does not show that resveratrol supplements reliably improve health or prevent infections. You can ignore marketing claims unless better, larger studies show clear benefits.
conflicting evidenceThis is a table-heavy review of what resveratrol has actually done to inflammatory markers and immune endpoints in human trials. The recurring signals are modest reductions in CRP and TNF-alpha in metabolic populations, mixed effects in healthy adults, and no clear effect on infection incidence. Useful mainly as a reference for someone trying to reconcile positive-vs-null endpoints across studies.
Resveratrol's inflammatory endpoint effects are consistent in metabolic subgroups and inconsistent in healthy adults.
Not a formal meta-analysis. The table combines primary and secondary endpoints across studies of very different design.
Cited by
1 encyclopedia entries reference this study.